Hemagglutination mediated by the spike protein of cell-adapted bovine torovirus

Arch Virol. 2013 Jul;158(7):1561-6. doi: 10.1007/s00705-013-1636-4. Epub 2013 Feb 19.

Abstract

Bovine torovirus (BToV)-Aichi, recently isolated in cultured cells, showed hemagglutination (HA) activity, although the virus has a truncated hemagglutinin-esterase (HE) protein, judging from its gene structure, indicating the existence of another viral protein with HA activity. We examined whether the spike (S) protein possesses HA activity. A BToV antiserum used in this study, reactive to S but not to HE, inhibited HA activity. Furthermore, cells infected with BToV and those expressing S showed hemadsorption (HAD) activity, which was inhibited by the anti-BToV serum; however, HAD activity by expressed HE was not blocked. These data indicate that the S protein of BToV-Aichi is responsible for its HA activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Erythrocytes / virology
  • Hemagglutination*
  • Membrane Glycoproteins / metabolism*
  • Spike Glycoprotein, Coronavirus
  • Torovirus / pathogenicity*
  • Viral Envelope Proteins / metabolism*
  • Virulence Factors / metabolism*
  • Virus Attachment

Substances

  • Membrane Glycoproteins
  • Spike Glycoprotein, Coronavirus
  • Viral Envelope Proteins
  • Virulence Factors
  • spike glycoprotein, SARS-CoV
  • spike protein, mouse hepatitis virus